{
  "main_header": {
    "sid": 178818,
    "name": "Ajanta Pharma",
    "stock_name": "Ajanta Pharma",
    "full_name": "Ajanta Pharma Ltd.",
    "name_url": "stocks-analysis/ajanta-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,626.60",
    "chg": 0.35,
    "chgp": "0.01%",
    "dir": 1,
    "prev_price": "2,626.25",
    "mcapval": "32,815.59 Cr",
    "mcap": "Mid Cap",
    "scripcode": 532331,
    "symbol": "AJANTPHARM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE031B01049",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "2.84 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ajanta-pharma-178818-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Ajanta Pharma falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-ajanta-pharma-fallingrising-3742384",
        "imagepath": "",
        "date": "2025-12-03 00:36:36",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Outperformance</strong></p>\n<p>Ajanta Pharma's stock has demonstrated resilience in the short term, outperforming its sector by 1.08% on the day. The stock has been on a three-day consecutive gain streak, delivering a cumulative return of 2.24% over this period. This upward trajectory is supported by the stock trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained buying interest and positive technical momentum.</p>\n<p>Investor participation has also increased, with delivery volumes on 01 Dec rising by over 20% compared to the five-day average, indicating heightened confidence among market participants. The stock's liquidity remains adequate, allowing for trade sizes of approximately ₹0...."
      },
      {
        "title": "Ajanta Pharma’s Evaluation Revised Amidst Mixed Financial and Market Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ajanta-pharma-downgraded-to-sell-by-marketsmojo-amid-valuation-and-trend-concerns-3730718",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AjantaPharma_mojoScore_3730718.png",
        "date": "2025-11-26 09:46:59",
        "description": "Ajanta Pharma has experienced a revision in its market evaluation, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of subdued stock performance and a complex interplay of valuation and operational metrics within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Ajanta Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ajanta-pharma-technically-bullish-or-bearish-3727461",
        "imagepath": "",
        "date": "2025-11-25 08:29:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Technical Trend Shift</strong></p>\n<p>As of 24 Nov 2025, Ajanta Pharma’s technical trend has transitioned from a clear bearish stance to a mildly bearish one. This subtle change suggests that while the stock is not yet in a confirmed uptrend, the intensity of selling pressure has eased somewhat. Investors should note that a mildly bearish trend often indicates consolidation or a potential base-building phase before a decisive move.</p>\n<p><strong>Momentum Indicators: Mixed Signals</strong></p>\n<p>Examining momentum oscillators reveals a complex scenario. The Moving Average Convergence Divergence (MACD) indicator shows a mildly bullish signal on the weekly chart, hinting at some short-term upward momentum. However, the monthly MACD remains mildly bearish, reflecting longer-term caution..."
      },
      {
        "title": "Ajanta Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-technical-momentum-shifts-amid-mixed-indicator-signals-3727310",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AjantaPharma_technicaldot_3727310.png",
        "date": "2025-11-25 08:01:13",
        "description": "Ajanta Pharma's recent price momentum reflects a nuanced shift in technical indicators, signalling a transition from a predominantly bearish stance to a more balanced outlook. The stock's performance, juxtaposed with key technical metrics such as MACD, RSI, and moving averages, reveals a complex market assessment amid broader sector dynamics."
      },
      {
        "title": "Ajanta Pharma Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-faces-bearish-momentum-amid-mixed-technical-signals-3723615",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AjantaPharma_technicaldot_3723615.png",
        "date": "2025-11-24 08:00:37",
        "description": "Ajanta Pharma's recent price action reflects a notable shift in technical momentum, with a blend of bearish and bullish signals emerging across key indicators. The stock's current trading dynamics and comparative performance against benchmarks warrant close examination for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Ajanta Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ajanta-pharma-technically-bullish-or-bearish-3716857",
        "imagepath": "",
        "date": "2025-11-20 08:10:29",
        "description": "As of 19 November 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by several key indicators. The MACD on a weekly basis is mildly bullish, but the monthly MACD is mildly bearish, indicating mixed signals. The RSI shows no signal on the weekly chart but is bullish on the monthly, suggesting some strength in the longer term. Bollinger Bands and KST are both bearish on the weekly and monthly charts, reinforcing the bearish sentiment. Moving averages indicate a mildly bearish trend on the daily timeframe. Overall, while there are some bullish signals in the longer timeframes, the prevailing sentiment remains mildly bearish...."
      },
      {
        "title": "Ajanta Pharma Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-technical-momentum-shifts-amid-mixed-indicator-signals-3717053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AjantaPharma_technicaldot_3717053.png",
        "date": "2025-11-20 08:00:53",
        "description": "Ajanta Pharma . has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. The stock’s recent price movements and technical signals suggest a cautious market stance amid broader sectoral and benchmark comparisons."
      },
      {
        "title": "Is Ajanta Pharma technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-ajanta-pharma-technically-bullish-or-bearish-3713807",
        "imagepath": "",
        "date": "2025-11-19 08:13:43",
        "description": "As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating bearish momentum, and the weekly and monthly Bollinger Bands also signaling bearish conditions. The MACD shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, suggesting mixed signals across time frames. The KST and Dow Theory are both bearish on the weekly and monthly, reinforcing the bearish outlook. Overall, the combination of these indicators points to a bearish sentiment for Ajanta Pharma...."
      },
      {
        "title": "Ajanta Pharma Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ajanta-pharma-technical-momentum-shifts-amid-bearish-signals-3714161",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AjantaPharma_technicaldot_3714161.png",
        "date": "2025-11-19 08:01:05",
        "description": "Ajanta Pharma . has experienced a notable shift in its technical parameters, reflecting a change in price momentum and mixed signals from key technical indicators. The stock’s current price stands at ₹2,459.20, down from the previous close of ₹2,503.30, with a day change of -1.76%. This movement occurs against a backdrop of evolving technical trends and market comparisons."
      }
    ],
    "total": 584,
    "sid": "178818",
    "stock_news_url": "https://www.marketsmojo.com/news/ajanta-pharma-178818"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "28-Nov-2025",
      "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 26 2025 for Aayush Agrawal trustee Aayush Agrawal Trust",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011",
      "datetime": "13-Nov-2025",
      "details": "The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on November 13 2025 for Ravi Agrawal trustee Ravi Agrawal Trust",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "06-Nov-2025",
      "details": "Pls find enclosed Written Transcript of Earnings Call",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has declared <strong>1400%</strong> dividend, ex-date: 10 Nov 25",
          "dt": "2025-11-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>2:5</strong> stock split, ex-date: 20 Mar 15",
          "dt": "2015-03-20",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Ajanta Pharma Ltd. has announced <strong>1:2</strong> bonus issue, ex-date: 22 Jun 22",
          "dt": "2022-06-22",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Ajanta Pharma falling/rising?

2025-12-03 00:36:36

Recent Price Movement and Market Outperformance

Ajanta Pharma's stock has demonstrated resilience in the short term, outperforming its sector by 1.08% on the day. The stock has been on a three-day consecutive gain streak, delivering a cumulative return of 2.24% over this period. This upward trajectory is supported by the stock trading above all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained buying interest and positive technical momentum.

Investor participation has also increased, with delivery volumes on 01 Dec rising by over 20% compared to the five-day average, indicating heightened confidence among market participants. The stock's liquidity remains adequate, allowing for trade sizes of approximately ₹0....

Read More

Ajanta Pharma’s Evaluation Revised Amidst Mixed Financial and Market Signals

2025-11-26 09:46:59

Ajanta Pharma has experienced a revision in its market evaluation, reflecting a nuanced shift in its financial and technical outlook. This adjustment comes amid a backdrop of subdued stock performance and a complex interplay of valuation and operational metrics within the Pharmaceuticals & Biotechnology sector.

Read More

Is Ajanta Pharma technically bullish or bearish?

2025-11-25 08:29:32

Recent Technical Trend Shift

As of 24 Nov 2025, Ajanta Pharma’s technical trend has transitioned from a clear bearish stance to a mildly bearish one. This subtle change suggests that while the stock is not yet in a confirmed uptrend, the intensity of selling pressure has eased somewhat. Investors should note that a mildly bearish trend often indicates consolidation or a potential base-building phase before a decisive move.

Momentum Indicators: Mixed Signals

Examining momentum oscillators reveals a complex scenario. The Moving Average Convergence Divergence (MACD) indicator shows a mildly bullish signal on the weekly chart, hinting at some short-term upward momentum. However, the monthly MACD remains mildly bearish, reflecting longer-term caution...

Read More

Ajanta Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-11-25 08:01:13

Ajanta Pharma's recent price momentum reflects a nuanced shift in technical indicators, signalling a transition from a predominantly bearish stance to a more balanced outlook. The stock's performance, juxtaposed with key technical metrics such as MACD, RSI, and moving averages, reveals a complex market assessment amid broader sector dynamics.

Read More

Ajanta Pharma Technical Momentum Shifts Amid Mixed Indicator Signals

2025-11-24 08:00:37

Ajanta Pharma's recent price action reflects a notable shift in technical momentum, with a blend of bearish and bullish signals emerging across key indicators. The stock's current trading dynamics and comparative performance against benchmarks warrant close examination for investors navigating the Pharmaceuticals & Biotechnology sector.

Read More

Is Ajanta Pharma technically bullish or bearish?

2025-11-20 08:10:29

As of 19 November 2025, the technical trend has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by several key indicators. The MACD on a weekly basis is mildly bullish, but the monthly MACD is mildly bearish, indicating mixed signals. The RSI shows no signal on the weekly chart but is bullish on the monthly, suggesting some strength in the longer term. Bollinger Bands and KST are both bearish on the weekly and monthly charts, reinforcing the bearish sentiment. Moving averages indicate a mildly bearish trend on the daily timeframe. Overall, while there are some bullish signals in the longer timeframes, the prevailing sentiment remains mildly bearish....

Read More

Ajanta Pharma Technical Momentum Shifts Amid Mixed Market Signals

2025-11-20 08:00:53

Ajanta Pharma . has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. The stock’s recent price movements and technical signals suggest a cautious market stance amid broader sectoral and benchmark comparisons.

Read More

Is Ajanta Pharma technically bullish or bearish?

2025-11-19 08:13:43

As of 18 November 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include the daily moving averages indicating bearish momentum, and the weekly and monthly Bollinger Bands also signaling bearish conditions. The MACD shows a mildly bullish signal on the weekly but is mildly bearish on the monthly, suggesting mixed signals across time frames. The KST and Dow Theory are both bearish on the weekly and monthly, reinforcing the bearish outlook. Overall, the combination of these indicators points to a bearish sentiment for Ajanta Pharma....

Read More

Ajanta Pharma Technical Momentum Shifts Amid Mixed Indicator Signals

2025-11-19 08:01:05

Ajanta Pharma . has experienced a notable shift in its technical parameters, reflecting a change in price momentum and mixed signals from key technical indicators. The stock’s current price stands at ₹2,459.20, down from the previous close of ₹2,503.30, with a day change of -1.76%. This movement occurs against a backdrop of evolving technical trends and market comparisons.

Read More

View All News